Copertina

Effects of a High‐Fat Meal on the Pharmacokinetics of Olverembatinib in Patients With Chronic Myeloid Leukemia

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Hengbang Wang, Yun Yang, Zi Chen, Min Yu, Lixin Jiang, Lichuang Men, Hua Yan, Dajun Yang, Yifan Zhai
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Clinical and Translational Science
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Pharmacokinetics of olverembatinib (HQP1351) in the presence of a strong CYP3A4 inhibitor (itraconazole) or inducer (rifampin) in healthy volunteers
di: Hengbang Wang, et al.
Pubblicazione: (2024)

Serum Haptoglobin as a Predictor of Treatment Response in Patients With Chronic Spontaneous Urticaria
di: Kun‐Woo Park, et al.
Pubblicazione: (2026)

The Effect of Ecopipam on the Pharmacokinetics of Concomitant Medications
di: Virginia D. Schmith, et al.
Pubblicazione: (2026)

Effect of Valemetostat on the Pharmacokinetics of Midazolam and Digoxin: A Phase 1 Drug–Drug Interaction Study in Patients With Non‐Hodgkin Lymphoma
di: Masaya Tachibana, et al.
Pubblicazione: (2025)

Population Pharmacokinetic and Pharmacokinetic‐Pharmacodynamic Modeling of Serum M‐Protein Response for Modakafusp Alfa in a Phase 1/2 Study of Patients With Relapsed or Refractory Multiple Myeloma
di: Cheryl Li, et al.
Pubblicazione: (2025)

Prediction factors and models for chronic kidney disease in type 2 diabetes mellitus: A review of the literature
di: Yan Yang, et al.
Pubblicazione: (2024)

Effect of E7777 Immunogenicity on Pharmacokinetics, Efficacy, and Safety in Adult Patients With Relapsed or Refractory Cutaneous T‐Cell Lymphoma
di: Theingi M. Thway, et al.
Pubblicazione: (2025)

Pharmacokinetics, pharmacodynamics, and safety of frunexian in healthy Chinese volunteer adults: A randomized dose‐escalation phase I study
di: Jia‐yu Zhang, et al.
Pubblicazione: (2024)

Elexacaftor/Tezacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients With Cystic Fibrosis
di: Ngoc Hoa Truong, et al.
Pubblicazione: (2025)

Real‐World Impact of Amiodarone on Apixaban Population Pharmacokinetics in Hospitalized Patients
di: Samantha Kolowrat, et al.
Pubblicazione: (2025)

Safety, Tolerability, and Pharmacokinetics of SC1011 (Sufenidone), a Novel Antifibrotic Small Molecule, in Phase 1 Studies in Healthy Subjects
di: Yun Liu, et al.
Pubblicazione: (2025)

Distinct Effects of Biological Treatments on Eosinophils and Neutrophils in Chronic Rhinosinusitis With Nasal Polyp Patients
di: Sharon Van Nevel, et al.
Pubblicazione: (2025)

Evaluation of the Effect of Food and Formulation on the Pharmacokinetics of the SHP2 Inhibitor Migoprotafib Within a Phase I Study in Cancer Patients
di: Julia Suchomel, et al.
Pubblicazione: (2026)

Pharmacokinetics and Safety of Fixed‐Dose Versus Separate Enavogliflozin/Gemigliptin Combinations, and Food Effect on Enavogliflozin in Healthy Korean Subjects
di: Young‐Sim Choi, et al.
Pubblicazione: (2025)

Impact of Pharmacokinetic Gene Polymorphisms on Statin‐Induced Myotoxicity in Thai Patients Treated With Simvastatin
di: Sayanit Tipnoppanon, et al.
Pubblicazione: (2026)

Population Pharmacokinetics and Exposure–Response Analysis of Serplulimab in Small Cell Lung Cancer Patients
di: Kun Wang, et al.
Pubblicazione: (2025)

Population Pharmacokinetics and Exposure–Response Analyses for Capivasertib in Combination With Fulvestrant in Patients With Breast Cancer
di: Carlos Fernandez Teruel, et al.
Pubblicazione: (2025)

Impact of Stress Hyperglycemia Ratio on Adverse Outcomes in Patients With Chronic Thromboembolic Pulmonary Hypertension
di: Yijia Wang, et al.
Pubblicazione: (2025)

Pharmacokinetics and Toxicity of Dimethylacetamide and Its Metabolite in Pediatric Patients Treated With High Dose Intravenous Busulphan
di: Fadwa Benkessou, et al.
Pubblicazione: (2025)

Ethnic Sensitivity Assessment of Mosunetuzumab Pharmacokinetics and Pharmacodynamics in Chinese Patients With Relapsed or Refractory Follicular Lymphoma
di: Junyi Li, et al.
Pubblicazione: (2025)

Pharmacokinetics as a Biomarker
di: John A. Wagner, et al.
Pubblicazione: (2026)

Genotype–Specific Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers
di: Jumar Etkins, et al.
Pubblicazione: (2025)

Challenges in Extrapolating Healthy Volunteer Pharmacokinetics to Oncology Populations: Advocating for a Holistic Perspective
di: Yan Ji, et al.
Pubblicazione: (2025)

Evaluation of Innate Immune System, Body Habitus, and Sex on the Pharmacokinetics and Pharmacodynamics of Anetumab Ravtansine in Patients With Cancer
di: Li Chen, et al.
Pubblicazione: (2025)

Emapalumab in Patients With Macrophage Activation Syndrome Associated With Still's Disease: A Population Pharmacokinetic/Pharmacodynamic Analysis
di: Patrick Brossard
Pubblicazione: (2025)

Pharmacokinetic Profiles of Lansoprazole in Patients With Morbid Obesity Post‐Roux‐en‐Y Gastric Bypass Surgery
di: Suthep Udomsawaengsup, et al.
Pubblicazione: (2025)

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of ALXN1820 (Tarperprumig) in Healthy Adults: Results of a Phase I Study
di: Avner Sandhu, et al.
Pubblicazione: (2025)

Population Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy: Influence of Adsorptive Membranes
di: Chidtawan Hirunsomboon, et al.
Pubblicazione: (2026)

Population Pharmacokinetic Model‐Based Optimization of Linezolid Dosing in Hematooncological Patients With Suspected or Proven Gram‐Positive Sepsis
di: Alžběta Zavřelová, et al.
Pubblicazione: (2025)

Assessment of Pharmacokinetics and Food Effect of AD‐109, a Novel Formulation of Rivaroxaban 18 mg
di: Hyunwook Ryu, et al.
Pubblicazione: (2025)

Causal Effects of Renin–Angiotensin–Aldosterone System Inhibition on Renal Function in Patients With Chronic Kidney Disease: A Quasi‐Experimental Study
di: Tae Ryom Oh, et al.
Pubblicazione: (2026)

Patient‐Reported Outcome Measures as Predictive Tools for Disease Control in Chronic Rhinosinusitis With Nasal Polyps: A Prospective Study
di: Chen Zhang, et al.
Pubblicazione: (2025)

Effect of Rifampicin on the Pharmacokinetics of Valemetostat and Its Primary Metabolite: A Phase 1 Study in Healthy Participants
di: Masaya Tachibana, et al.
Pubblicazione: (2025)

No Effect of Immunogenicity on Pharmacokinetics, Efficacy, and Safety of the Oligonucleotide Telomerase Inhibitor Imetelstat in Lower‐Risk Myelodysplastic Syndromes
di: Ashley L. Lennox, et al.
Pubblicazione: (2025)

Population Pharmacokinetic Model Assessment of the Effects of Body Weight on Risk of Drug–Drug Interactions After Posaconazole Discontinuation
di: Rebecca E. Wrishko, et al.
Pubblicazione: (2026)

Effect of Cladribine Tablets on the Pharmacokinetics of a Combined Oral Contraceptive in Pre‐Menopausal Women With Relapsing Multiple Sclerosis
di: Robert Hermann, et al.
Pubblicazione: (2025)

Pharmacokinetics and Safety of Polaprezinc Granules Oral Administration in Healthy Chinese Volunteers Under Fasting and Fed Conditions
di: Min Xiao, et al.
Pubblicazione: (2025)

Pharmacokinetic‐Pharmacodynamic Model of Paclitaxel‐Induced Peripheral Neuropathy
di: Yuchen Sun, et al.
Pubblicazione: (2025)

Pharmacokinetics of Belumosudil and Its Metabolites in Individuals With Hepatic Impairment
di: Olivier Schueller, et al.
Pubblicazione: (2025)

Real‐World Efficacy and Safety of Tofacitinib for Patients With Alopecia Areata: A Retrospective Multi‐Center Cohort Study
di: Yifan Jin, et al.
Pubblicazione: (2026)